107 related articles for article (PubMed ID: 30044673)
1. Investigation of disposition for TAK-448, a synthetic peptide of kisspeptin analog, in rats and dogs using the radiolabeled TAK-448 suitable for pharmacokinetic study.
Moriya Y; Kogame A; Tagawa Y; Morohashi A; Kondo T; Asahi S
Xenobiotica; 2019 Jul; 49(7):833-839. PubMed ID: 30044673
[TBL] [Abstract][Full Text] [Related]
2. The Enhancement of Subcutaneous First-Pass Metabolism Causes Nonlinear Pharmacokinetics of TAK-448 after a Single Subcutaneous Administration to Rats.
Moriya Y; Kogame A; Tagawa Y; Morohashi A; Kondo T; Asahi S; Benet LZ
Drug Metab Dispos; 2019 Sep; 47(9):1004-1012. PubMed ID: 31201213
[TBL] [Abstract][Full Text] [Related]
3. Disposition of TAK-044, a new endothelin antagonist, in rats and dogs.
Maeshiba Y; Takeuchi T; Kondo T; Yamashita K; Tsukuda R; Yoshimura Y
Arzneimittelforschung; 2002; 52(8):587-92. PubMed ID: 12236045
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of TAK-475, a Squalene Synthase Inhibitor, in Rats and Dogs.
Ebihara T; Teshima K; Kondo T; Tagawa Y; Moriwaki T; Asahi S
Drug Res (Stuttg); 2016 Jun; 66(6):287-92. PubMed ID: 26839207
[TBL] [Abstract][Full Text] [Related]
5. Disposition of the new antirheumatic agent ethyl 4-(3,4-dimethoxyphenyl)- 6,7-dimethoxy-2-(1,2,4-triazol-1-ylmethyl)quinoline-3-carboxylate (TAK-603) in rats and dogs.
Tagawa Y; Kiyota Y; Yoshimura Y; Motohashi M; Tanayama S
Arzneimittelforschung; 1998 Jul; 48(7):750-7. PubMed ID: 9706376
[TBL] [Abstract][Full Text] [Related]
6. Disposition and metabolism of TAK-438 (vonoprazan fumarate), a novel potassium-competitive acid blocker, in rats and dogs.
Kogame A; Takeuchi T; Nonaka M; Yamasaki H; Kawaguchi N; Bernards A; Tagawa Y; Morohashi A; Kondo T; Moriwaki T; Asahi S
Xenobiotica; 2017 Mar; 47(3):255-266. PubMed ID: 27225050
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of pharmacokinetics/pharmacodynamics and efficacy of one-month depots of TAK-448 and TAK-683, investigational kisspeptin analogs, in male rats and an androgen-dependent prostate cancer model.
Tanaka A; Nakata D; Masaki T; Kusaka M; Watanabe T; Matsui H
Eur J Pharmacol; 2018 Mar; 822():138-146. PubMed ID: 29355559
[TBL] [Abstract][Full Text] [Related]
8. Pharmacologic profiles of investigational kisspeptin/metastin analogues, TAK-448 and TAK-683, in adult male rats in comparison to the GnRH analogue leuprolide.
Matsui H; Masaki T; Akinaga Y; Kiba A; Takatsu Y; Nakata D; Tanaka A; Ban J; Matsumoto S; Kumano S; Suzuki A; Ikeda Y; Yamaguchi M; Watanabe T; Ohtaki T; Kusaka M
Eur J Pharmacol; 2014 Jul; 735():77-85. PubMed ID: 24747751
[TBL] [Abstract][Full Text] [Related]
9. Disposition and metabolism of the new hypocholesterolemic compound S-8921 in rats and dogs.
Yamaguchi T; Nakajima Y; Mizobuchi M; Inazawa K; Kanazu T; Kadono K; Ohkawa T; Iwatani K
Arzneimittelforschung; 1998 Oct; 48(10):995-1006. PubMed ID: 9825117
[TBL] [Abstract][Full Text] [Related]
10. Disposition of the Highly Fat Distributed Compound 1-(4-Methoxyphenyl)-4-(2,2,4,6,7-Pentamethyl -2,3-Dihydro-1-Benzofuran-5-yl)Piperazine (TAK-357) in Rats and Dogs.
Goto A; Moriya Y; Mandai T; Wakabayashi T; Tsukamoto T; Tagawa Y; Kondo T; Asahi S
Drug Res (Stuttg); 2017 Jan; 67(1):38-45. PubMed ID: 27728931
[TBL] [Abstract][Full Text] [Related]
11. Disposition of the new potent acetylcholinesterase inhibitor 8-[3-[1-[(3-fluorophenyl)methyl]-4-piperidiny]-1-oxopropyl]-1, 2, 5, 6-tetrahydro-4H-pyrrolo [3, 2, 1-ij] quinolin-4-one (TAK-802) in rats, dogs and monkeys.
Kakehi M; Tagawa Y; Kondo T; Asahi S
Drug Res (Stuttg); 2013 Jun; 63(6):293-9. PubMed ID: 23585302
[TBL] [Abstract][Full Text] [Related]
12. The disposition of radioactivity after administration of the anthelminthic methyl-14C-5-cyclopropylcarbonyl-2-benzimidazole carbamate (ciclobendazole) to rats and dogs.
Brodie RR; Mayo BC; Chasseaud LF; Hawkins DR
Arzneimittelforschung; 1977; 27(3):593-8. PubMed ID: 577426
[TBL] [Abstract][Full Text] [Related]
13. Chronic administration of the metastin/kisspeptin analog KISS1-305 or the investigational agent TAK-448 suppresses hypothalamic pituitary gonadal function and depletes plasma testosterone in adult male rats.
Matsui H; Tanaka A; Yokoyama K; Takatsu Y; Ishikawa K; Asami T; Nishizawa N; Suzuki A; Kumano S; Terada M; Kusaka M; Kitada C; Ohtaki T
Endocrinology; 2012 Nov; 153(11):5297-308. PubMed ID: 23027808
[TBL] [Abstract][Full Text] [Related]
14. Usefulness of pharmacokinetic/efficacy analysis of an investigational kisspeptin analog, TAK-448, in quantitatively evaluating anti-tumor growth effect in the rat VCaP androgen-sensitive prostate cancer model.
Ishikawa K; Tanaka A; Kogame A; Watanabe T; Tagawa Y; Matsui H
Eur J Pharmacol; 2018 Jun; 828():126-134. PubMed ID: 29580912
[TBL] [Abstract][Full Text] [Related]
15. Investigation of the unique metabolic fate of ethyl (6R)-6- [N- (2-chloro-4-fluorophenyl) sulfamoyl] cyclohex-1-ene-1-carboxylate (TAK-242) in rats and dogs using two types of 14C-labeled compounds having different labeled positions.
Jinno F; Kakehi M; Takeuchi T; Tagawa Y; Kondo T; Asahi S
Arzneimittelforschung; 2011; 61(8):458-71. PubMed ID: 21950150
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics and disposition of L-692,429. A novel nonpeptidyl growth hormone secretagogue in preclinical species.
Leung KH; Cohn DA; Miller RR; Doss GA; Stearns RA; Simpson RE; Feeney WP; Chiu SH
Drug Metab Dispos; 1996 Jul; 24(7):753-60. PubMed ID: 8818572
[TBL] [Abstract][Full Text] [Related]
17. Disposition and metabolism of the G protein-coupled receptor 40 agonist TAK-875 (fasiglifam) in rats, dogs, and humans.
Kogame A; Lee R; Pan L; Sudo M; Nonaka M; Moriya Y; Higuchi T; Tagawa Y
Xenobiotica; 2019 Apr; 49(4):433-445. PubMed ID: 29557709
[TBL] [Abstract][Full Text] [Related]
18. Metabolism and disposition of 14C-granisetron in rat, dog and man after intravenous and oral dosing.
Clarke SE; Austin NE; Bloomer JC; Haddock RE; Higham FC; Hollis FJ; Nash M; Shardlow PC; Tasker TC; Woods FR
Xenobiotica; 1994 Nov; 24(11):1119-31. PubMed ID: 7701853
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetic and pharmacodynamic modeling of the metastin/kisspeptin analog, TAK-448, for its anti-tumor efficacy in a rat xenograft model.
Kogame A; Ishikawa K; DeJongh J; Tagawa Y; Matsui H; Moriya Y; Kondo T; Asahi S
Biopharm Drug Dispos; 2020 Jul; 41(7):283-294. PubMed ID: 32562504
[TBL] [Abstract][Full Text] [Related]
20. Disposition of [14C]velnacrine maleate in rats, dogs, and humans.
Turcan RG; Hillbeck D; Hartley TE; Gilbert PJ; Coe RA; Troke JA; Vose CW
Drug Metab Dispos; 1993; 21(6):1037-47. PubMed ID: 7905382
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
